XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
VYGR Voyager Therapeutics
- 4.230
- -0.150-3.42%
Close Feb 14 16:00 ET
- 4.240
- +0.010+0.24%
Post 19:33 ET
231.07MMarket Cap6.41P/E (TTM)
4.600High4.200Low442.05KVolume4.380Open4.380Pre Close1.90MTurnover1.02%Turnover Ratio1.42P/E (Static)54.63MShares10.66052wk High0.70P/B183.09MFloat Cap4.00152wk Low--Dividend TTM43.28MShs Float31.910Historical High--Div YieldTTM9.13%Amplitude2.460Historical Low4.292Avg Price1Lot Size
About Voyager Therapeutics Company
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Company Profile
SymbolVYGR
Company NameVoyager Therapeutics
Listing DateNov 11, 2015
Issue Price14.00
Founded2013
CEODr. Alfred W. Sandrock, Jr,M.D.,PhD
MarketNASDAQ
Employees162
Fiscal Year Ends12-31
Address75 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-857-259-5340
Company Executives
- Name
- Position
- Salary
- Dr. Alfred W. Sandrock, Jr,M.D.,PhD
- Director, President and Chief Executive Officer
- 3.17M
- Robin Swartz
- Chief Operating Officer
- 1.38M
- Dr. Todd Carter, PhD
- Chief Scientific Officer
- --
- Dr. Nathan Jorgensen, M.B.A.,PhD
- Chief Financial Officer and Principal Accounting Officer
- --
- Jacquelyn Fahey Sandell, J.D.
- Chief Legal Officer
- 1.68M
- Toby Ferguson
- Chief Medical Officer
- --
- Michael J. Higgins
- Chairman of the Board
- 281.28K
- Dr. Jude Onyia, PhD
- Director
- 452.32K
- Dr. Catherine J. Mackey, PhD
- Independent Director
- 250.78K
- Dr. Grace E. Colon, PhD
- Independent Director
- 432.23K
- Nancy Vitale
- Independent Director
- 255.28K
- James A. Geraghty
- Independent Director
- 263.78K
- Dr. Steven E. Hyman, M.D.
- Independent Director
- 255.78K
- Dr. George A. Scangos,PhD
- Independent Director
- 559.79K
- Dr. Glenn F. Pierce, M.D.,PhD
- Independent Director
- 248.78K
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!